Form 4: Inspire Medical Interim CFO's Stock Transaction

Inspire Medical Systems' Interim CFO, Richard Buchholz, reported a disposition of 327 shares for tax withholding related to a restricted stock unit award.

Summary

• Richard Buchholz, Interim CFO of Inspire Medical Systems, Inc. (INSP), reported a transaction on February 9, 2026.
• 327 shares of common stock were disposed of at a price of $66.33 per share.
• This disposition was due to shares being withheld by the Issuer to satisfy taxes incident to the vesting of a restricted stock unit award.
• Following this transaction, Buchholz directly beneficially owns 44,567 shares of common stock.
• This total includes 27 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan on December 31, 2025.
• Buchholz also indirectly beneficially owns 1,475 shares through his son.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While there was a disposition of shares, it was for tax purposes related to RSU vesting, which is a positive underlying event (compensation). The acquisition via ESPP also shows continued insider investment.

Positives

• The underlying event for the disposition was the vesting of a restricted stock unit (RSU) award, indicating compensation for the Interim CFO.
• The Interim CFO also acquired 27 shares through the Employee Stock Purchase Plan (ESPP), demonstrating continued investment in the company.

Negatives

• A disposition of shares occurred, although it was for tax purposes rather than a discretionary sale.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine insider transactions, such as tax-related dispositions from RSU vesting and ESPP acquisitions, are common across industries and generally do not signal significant shifts in company fundamentals or insider sentiment. These transactions reflect standard compensation practices and employee investment programs.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes. The underlying RSU vesting and ESPP acquisition are positive for executive alignment.
• Employees: The ESPP acquisition highlights the availability of employee stock purchase programs.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving tax withholding from RSU vesting and an ESPP acquisition. Such non-discretionary transactions typically have minimal impact on the company's fundamentals or stock price. The underlying RSU vesting and ESPP participation are generally positive signals of executive compensation and employee alignment, but do not warrant a change in investment stance based solely on this filing. Therefore, a 'hold' recommendation is appropriate.

Keywords

Inspire Medical Systems, INSP, Form 4, Insider Transaction, Richard Buchholz, Interim CFO, Stock Sale, Tax Withholding, Restricted Stock Units, ESPP, Employee Stock Purchase Plan, Beneficial Ownership